Literature DB >> 21180540

Assessing the risks and benefits of treating Helicobacter pylori infection.

Ivan F N Hung1, Benjamin C Y Wong.   

Abstract

Entities:  

Year:  2009        PMID： 21180540      PMCID： PMC3002520          DOI： 10.1177/1756283X08100279

Source DB:  PubMed          Journal:  Therap Adv Gastroenterol        ISSN： 1756-283X            Impact factor:   4.409


× No keyword cloud information.
  57 in total

1.  Role of Helicobacter pylori infection and non-steroidal anti-inflammatory drugs in peptic-ulcer disease: a meta-analysis.

Authors:  Jia Qing Huang; Subbaramiah Sridhar; Richard H Hunt
Journal:  Lancet       Date:  2002-01-05       Impact factor: 79.321

2.  Current concepts in the management of Helicobacter pylori infection: the Maastricht III Consensus Report.

Authors:  P Malfertheiner; F Megraud; C O'Morain; F Bazzoli; E El-Omar; D Graham; R Hunt; T Rokkas; N Vakil; E J Kuipers
Journal:  Gut       Date:  2006-12-14       Impact factor: 23.059

Review 3.  Role of Helicobacter pylori eradication in aspirin or non-steroidal anti-inflammatory drug users.

Authors:  George-V Papatheodoridis; Athanasios-J Archimandritis
Journal:  World J Gastroenterol       Date:  2005-07-07       Impact factor: 5.742

4.  Association of Helicobacter pylori infection with atrophic gastritis and intestinal metaplasia.

Authors:  K Ohkuma; M Okada; H Murayama; M Seo; K Maeda; M Kanda; N Okabe
Journal:  J Gastroenterol Hepatol       Date:  2000-10       Impact factor: 4.029

Review 5.  Helicobacter pylori.

Authors:  B J Marshall
Journal:  Am J Gastroenterol       Date:  1994-08       Impact factor: 10.864

Review 6.  Review article: should we kill or should we save Helicobacter pylori?

Authors:  R H Hunt; K Sumanac; J Q Huang
Journal:  Aliment Pharmacol Ther       Date:  2001-06       Impact factor: 8.171

7.  Association of Helicobacter pylori infection with gastric carcinoma: a meta-analysis.

Authors:  G D Eslick; L L Lim; J E Byles; H H Xia; N J Talley
Journal:  Am J Gastroenterol       Date:  1999-09       Impact factor: 10.864

Review 8.  Helicobacter pylori and gastroesophageal reflux disease.

Authors:  D C Metz; J A Kroser
Journal:  Gastroenterol Clin North Am       Date:  1999-12       Impact factor: 3.806

Review 9.  Eradication therapy in Helicobacter pylori positive peptic ulcer disease: systematic review and economic analysis.

Authors:  Alexander C Ford; Brendan C Delaney; David Forman; Paul Moayyedi
Journal:  Am J Gastroenterol       Date:  2004-09       Impact factor: 10.864

10.  Does Helicobacter pylori eradication affect symptoms in nonulcer dyspepsia: a 5-year follow-up study.

Authors:  D McNamara; M Buckley; J Gilvarry; C O'Morain
Journal:  Helicobacter       Date:  2002-10       Impact factor: 5.753
View more
  9 in total

1.  A win for the patient: Direct patient notification improves treatment rates of active Helicobacter pylori infection.

Authors:  Sriharan Selvaratnam; Joey Yeoh; John Hsiang; Alasdair B Patrick
Journal:  Australas Med J       Date:  2014-08-31

Review 2.  Value of screening endoscopy in evaluation of esophageal, gastric and colon cancers.

Authors:  Tae H Ro; Michelle A Mathew; Subhasis Misra
Journal:  World J Gastroenterol       Date:  2015-09-07       Impact factor: 5.742

3.  Impacts of H. pylori mixed-infection and heteroresistance on clinical outcomes.

Authors:  Masoud Alebouyeh; Abbas Yadegar; Nastaran Farzi; Marzyieh Miri; Homayoon Zojaji; Somayeh Gharibi; Zeinab Fazeli; Naser Ebrahimi Daryani; Hamid Asadzadeh Aghdaei; Mohammad Reza Zali
Journal:  Gastroenterol Hepatol Bed Bench       Date:  2015

Review 4.  Tracking Strains in the Microbiome: Insights from Metagenomics and Models.

Authors:  Ilana L Brito; Eric J Alm
Journal:  Front Microbiol       Date:  2016-05-19       Impact factor: 5.640

5.  Probiotics improve the efficacy of standard triple therapy in the eradication of Helicobacter pylori: a meta-analysis.

Authors:  Christine S M Lau; Amanda Ward; Ronald S Chamberlain
Journal:  Infect Drug Resist       Date:  2016-12-07       Impact factor: 4.003

6.  The Effects of Synbiotic "Bifidobacterium lactis B94 plus Inulin" Addition on Standard Triple Therapy of Helicobacter pylori Eradication in Children.

Authors:  Gonca Handan Ustundag; Halime Altuntas; Yasemin Dilek Soysal; Furuzan Kokturk
Journal:  Can J Gastroenterol Hepatol       Date:  2017-06-01

7.  Temporin-SHa and Its Analogs as Potential Candidates for the Treatment of Helicobacter pylori.

Authors:  Hamza Olleik; Elias Baydoun; Josette Perrier; Akram Hijazi; Josette Raymond; Marine Manzoni; Lucas Dupuis; Ghislain Pauleau; Yvain Goudard; Bruno de La Villéon; Géraldine Goin; Philippe Sockeel; Muhammad Iqbal Choudhary; Eric Di Pasquale; Muhammad Nadeem-Ul-Haque; Hunain Ali; Arif Iftikhar Khan; Farzana Shaheen; Marc Maresca
Journal:  Biomolecules       Date:  2019-10-11

Review 8.  Helicobacter pylori infection: Beyond gastric manifestations.

Authors:  Maria Luísa Cordeiro Santos; Breno Bittencourt de Brito; Filipe Antônio França da Silva; Mariana Miranda Sampaio; Hanna Santos Marques; Natália Oliveira E Silva; Dulciene Maria de Magalhães Queiroz; Fabrício Freire de Melo
Journal:  World J Gastroenterol       Date:  2020-07-28       Impact factor: 5.742

9.  Disrupted human-pathogen co-evolution: a model for disease.

Authors:  Nuri Kodaman; Rafal S Sobota; Robertino Mera; Barbara G Schneider; Scott M Williams
Journal:  Front Genet       Date:  2014-08-25       Impact factor: 4.599
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.